United States

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders in the United States. Its product pipeline includes AXS-05 for major depressive disorder and resistant depression disorders, AXS-07 for migraine, AXS-12 for narcolepsy, and AXS-14 for fibromyalgia. The company has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation.

Axsome Therapeutics

Regional Marketer, Migraine (West Region)

Regional Marketer, Sleep (West Region)

Associate Director/Director, Government Pricing

Director, Market Access Deal Analytics

Regional Marketer, Alzheimer's Disease Agitation (Northeast Region)

Product Manager/Senior Product Manager, HCP Marketing, Migraine

Associate Director, IT SOX Compliance

Senior Manager, Field Effectiveness

Senior Manager, Pharmacovigilance Operations

Specialty Account Manager, Auvelity (Macon, GA)

Google

Produkto vadovas

Duomenų mokslininkas

Axsome Therapeutics

Axsome Therapeutics Atviros pozicijos

Ar pasiruošę kelti savo karjerą? Peržiūrėkite šias atviras pozicijas Axsome Therapeutics įmonėje.